Cargando…
Anti-inflammatory treatment induced regenerative oligodendrogenesis in parkinsonian mice
INTRODUCTION: The adult mammalian brain retains niches for neural stem cells (NSCs), which can generate glial and neuronal components of the brain tissue. However, it is barely established how chronic neuroinflammation, as it occurs in neurodegenerative diseases, such as Alzheimer's and Parkins...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580471/ https://www.ncbi.nlm.nih.gov/pubmed/22892385 http://dx.doi.org/10.1186/scrt124 |
_version_ | 1782260255432900608 |
---|---|
author | Worlitzer, Maik MA Bunk, Eva C Hemmer, Kathrin Schwamborn, Jens C |
author_facet | Worlitzer, Maik MA Bunk, Eva C Hemmer, Kathrin Schwamborn, Jens C |
author_sort | Worlitzer, Maik MA |
collection | PubMed |
description | INTRODUCTION: The adult mammalian brain retains niches for neural stem cells (NSCs), which can generate glial and neuronal components of the brain tissue. However, it is barely established how chronic neuroinflammation, as it occurs in neurodegenerative diseases, such as Alzheimer's and Parkinson's disease, affects adult neurogenesis and, therefore, modulates the brain's potential for self-regeneration. METHODS: Neural stem cell culture techniques, intraventricular tumor necrosis factor (TNF)-α infusion and the 6-hydroxydopamine mouse model were used to investigate the influence of neuroinflammation on adult neurogenesis in the Parkinson's disease background. Microscopic methods and behavioral tests were used to analyze samples. RESULTS: Here, we demonstrate that differences in the chronicity of TNF-α application to cultured NSCs result in opposed effects on their proliferation. However, chronic TNF-α treatment, mimicking Parkinson's disease associated neuroinflammation, shows detrimental effects on neural progenitor cell activity. Inversely, pharmacological inhibition of neuroinflammation in a 6-hydroxydopamine mouse model led to increased neural progenitor cell proliferation in the subventricular zone and neuroblast migration into the lesioned striatum. Four months after surgery, we measured improved Parkinson's disease-associated behavior, which was correlated with long-term anti-inflammatory treatment. But surprisingly, instead of newly generated striatal neurons, oligodendrogenesis in the striatum of treated mice was enhanced. CONCLUSIONS: We conclude that anti-inflammatory treatment, in a 6-hydroxydopamine mouse model for Parkinson's disease, leads to activation of adult neural stem cells. These adult neural stem cells generate striatal oligodendrocytes. The higher numbers of newborn oligodendrocytes possibly contribute to axonal stability and function in this mouse model of Parkinson's disease and thereby attenuate dysfunctions of basalganglian motor-control. |
format | Online Article Text |
id | pubmed-3580471 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-35804712013-02-26 Anti-inflammatory treatment induced regenerative oligodendrogenesis in parkinsonian mice Worlitzer, Maik MA Bunk, Eva C Hemmer, Kathrin Schwamborn, Jens C Stem Cell Res Ther Research INTRODUCTION: The adult mammalian brain retains niches for neural stem cells (NSCs), which can generate glial and neuronal components of the brain tissue. However, it is barely established how chronic neuroinflammation, as it occurs in neurodegenerative diseases, such as Alzheimer's and Parkinson's disease, affects adult neurogenesis and, therefore, modulates the brain's potential for self-regeneration. METHODS: Neural stem cell culture techniques, intraventricular tumor necrosis factor (TNF)-α infusion and the 6-hydroxydopamine mouse model were used to investigate the influence of neuroinflammation on adult neurogenesis in the Parkinson's disease background. Microscopic methods and behavioral tests were used to analyze samples. RESULTS: Here, we demonstrate that differences in the chronicity of TNF-α application to cultured NSCs result in opposed effects on their proliferation. However, chronic TNF-α treatment, mimicking Parkinson's disease associated neuroinflammation, shows detrimental effects on neural progenitor cell activity. Inversely, pharmacological inhibition of neuroinflammation in a 6-hydroxydopamine mouse model led to increased neural progenitor cell proliferation in the subventricular zone and neuroblast migration into the lesioned striatum. Four months after surgery, we measured improved Parkinson's disease-associated behavior, which was correlated with long-term anti-inflammatory treatment. But surprisingly, instead of newly generated striatal neurons, oligodendrogenesis in the striatum of treated mice was enhanced. CONCLUSIONS: We conclude that anti-inflammatory treatment, in a 6-hydroxydopamine mouse model for Parkinson's disease, leads to activation of adult neural stem cells. These adult neural stem cells generate striatal oligodendrocytes. The higher numbers of newborn oligodendrocytes possibly contribute to axonal stability and function in this mouse model of Parkinson's disease and thereby attenuate dysfunctions of basalganglian motor-control. BioMed Central 2012-08-14 /pmc/articles/PMC3580471/ /pubmed/22892385 http://dx.doi.org/10.1186/scrt124 Text en Copyright ©2012 Worlitzer et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Worlitzer, Maik MA Bunk, Eva C Hemmer, Kathrin Schwamborn, Jens C Anti-inflammatory treatment induced regenerative oligodendrogenesis in parkinsonian mice |
title | Anti-inflammatory treatment induced regenerative oligodendrogenesis in parkinsonian mice |
title_full | Anti-inflammatory treatment induced regenerative oligodendrogenesis in parkinsonian mice |
title_fullStr | Anti-inflammatory treatment induced regenerative oligodendrogenesis in parkinsonian mice |
title_full_unstemmed | Anti-inflammatory treatment induced regenerative oligodendrogenesis in parkinsonian mice |
title_short | Anti-inflammatory treatment induced regenerative oligodendrogenesis in parkinsonian mice |
title_sort | anti-inflammatory treatment induced regenerative oligodendrogenesis in parkinsonian mice |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580471/ https://www.ncbi.nlm.nih.gov/pubmed/22892385 http://dx.doi.org/10.1186/scrt124 |
work_keys_str_mv | AT worlitzermaikma antiinflammatorytreatmentinducedregenerativeoligodendrogenesisinparkinsonianmice AT bunkevac antiinflammatorytreatmentinducedregenerativeoligodendrogenesisinparkinsonianmice AT hemmerkathrin antiinflammatorytreatmentinducedregenerativeoligodendrogenesisinparkinsonianmice AT schwambornjensc antiinflammatorytreatmentinducedregenerativeoligodendrogenesisinparkinsonianmice |